General clinical biochemistry, quality control, assay validation

Administration of staff, routine work and research

Establishment of biobanks

Design of biomarker monitoring trials phase I - IV

Cancer biomarkers

Networking at national and international level

Interpretation of serial protein cancer biomarker data i.e. CA 125, CA 15.3 and PSA in clinical studies

Criteria to interpret serial biomarker data investigated in pre-clinical computer based simulation studies

Circulating tumor cells

Hypermethylated DNA and metastatic breast cancer

Clinical utility of solid tumor epigenetics

Different approaches to assess the significance of a change in serial concentrations

As above

None